MDMEDNAX Inc
MD
MEDNAX Inc455
Mkt Cap
$1.56BVolume
1.92M52W High
$24.9952W Low
$11.84PE Ratio
9.71MD Fundamentals
Price
$18.82Prev Close
$19.30Open
$19.2550D MA
$21.58Beta
0.84Avg. Volume
559,762.25EPS (Annual)
$1.94P/B
1.80Rev/Employee
$291,079.70$1,958.77
Poll
Earnings Recap
• Reported GAAP EPS of $0.40 up 11.11% YoY • Reported revenue of $493.77M down -1.71% YoY • On a preliminary basis, Pediatrix anticipates its 2026 Adjusted EBITDA will be in a range of $280M to $300M, as defined in the company's financial report.
Bullish
Pediatrix saw solid same-unit revenue growth from reimbursement factors, increased net income, and improved its cash position while significantly reducing transformational and restructuring expenses.
Bearish
Pediatrix experienced decreased net revenue, lower Adjusted EBITDA due to higher compensation, and faces significant healthcare industry headwinds, including economic conditions and regulatory uncertainties.